Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2022

27.05.2021 | Original Article

Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention

verfasst von: Lisa Glass, Haila Asefa, Michael Volk, Anna S. Lok, Monica A. Tincopa

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Lifestyle modification is currently the only treatment for nonalcoholic fatty liver disease (NAFLD). The most effective way to motivate behavior change in this population is not well understood.

Aims

The aims of this study were to characterize the association between patient disease knowledge, attitudes, and behaviors and to determine the impact of an educational intervention.

Methods

Adults with NAFLD had the following assessed before and after an educational intervention: (1) disease knowledge; (2) health-related quality of life (HRQOL); (3) physical activity; (4) diet; (5) stages of change; and (6) clinical variables.

Results

Median age of the cohort (N = 248) was 53.5, 46% were male, 85% were white, and median body mass index was 33.9. Forty-eight percentage had nonalcoholic steatohepatitis, and 28% had cirrhosis. The median correct knowledge score was 73.6%, median Chronic Liver Disease Questionnaire-NAFLD was 5.2/7, and diet score was 7/16 (higher indicating unhealthy diets). The cohort was sedentary at baseline, with 46% and 60% in active phases of change for nutrition and physical activity, respectively. Fifty-six (22%) had all three high-risk behaviors (sedentary, poor diet scores, low stage of change), which was independently associated with depression. The educational intervention improved diet scores, HRQOL, stages of change, and weight.

Conclusions

Despite good disease knowledge, NAFLD participants were sedentary and 1/4 had high-risk lifestyle behaviors. An educational intervention had positive impacts on clinical outcomes, though effect size was small. Pairing educational interventions with targeted interventions to motivate behavior change can improve care for patients with NAFLD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Younossi ZM, Koenig AB, Abdelatif D et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73–84.CrossRef Younossi ZM, Koenig AB, Abdelatif D et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73–84.CrossRef
2.
Zurück zum Zitat Rafiq N, Bai C, Fang Y et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009;7:234–238.CrossRef Rafiq N, Bai C, Fang Y et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009;7:234–238.CrossRef
3.
Zurück zum Zitat Dunn W, Xu R, Wingard DL et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103:2263–2271.CrossRef Dunn W, Xu R, Wingard DL et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103:2263–2271.CrossRef
4.
Zurück zum Zitat Promrat K, Kleiner DE, Niemeier HM et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121–129.CrossRef Promrat K, Kleiner DE, Niemeier HM et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121–129.CrossRef
5.
Zurück zum Zitat Huang MA, Greenson JK, Chao C et al. One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005;100:1072–1081.CrossRef Huang MA, Greenson JK, Chao C et al. One-year intense nutritional counseling results in histological improvement in patients with nonalcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005;100:1072–1081.CrossRef
6.
Zurück zum Zitat Dalle Grave R, Calugi S, Centis E et al. Cognitive-behavioral strategies to increase the adherence to exercise in the management of obesity. J Obes 2011;2011:348293.CrossRef Dalle Grave R, Calugi S, Centis E et al. Cognitive-behavioral strategies to increase the adherence to exercise in the management of obesity. J Obes 2011;2011:348293.CrossRef
7.
Zurück zum Zitat Tseng HM, Liao SF, Wen YP et al. Stages of change concept of the transtheoretical model for healthy eating links health literacy and diabetes knowledge to glycemic control in people with type 2 diabetes. Prim Care Diabetes 2017;11:29–36.CrossRef Tseng HM, Liao SF, Wen YP et al. Stages of change concept of the transtheoretical model for healthy eating links health literacy and diabetes knowledge to glycemic control in people with type 2 diabetes. Prim Care Diabetes 2017;11:29–36.CrossRef
9.
Zurück zum Zitat Wieland AC, Mettler P, McDermott MT et al. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol 2015;49:e6–e10.CrossRef Wieland AC, Mettler P, McDermott MT et al. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol 2015;49:e6–e10.CrossRef
10.
Zurück zum Zitat Alemany-Pagès M, Moura-Ramos M, Araújo S et al. Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? BMC Public Health 2020;20:1142.CrossRef Alemany-Pagès M, Moura-Ramos M, Araújo S et al. Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? BMC Public Health 2020;20:1142.CrossRef
11.
Zurück zum Zitat Cleveland ER, Ning H, Vos MB et al. Low awareness of nonalcoholic fatty liver disease in a population-based cohort sample: the CARDIA study. J Gen Internal Med 2019;34:2772–2778.CrossRef Cleveland ER, Ning H, Vos MB et al. Low awareness of nonalcoholic fatty liver disease in a population-based cohort sample: the CARDIA study. J Gen Internal Med 2019;34:2772–2778.CrossRef
13.
Zurück zum Zitat Hallsworth K, Thoma C, Moore S et al. Nonalcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterol 2015;6:44–51.CrossRef Hallsworth K, Thoma C, Moore S et al. Nonalcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterol 2015;6:44–51.CrossRef
15.
Zurück zum Zitat Paxton AE, Strycker LA, Toobert DJ et al. Starting the conversation performance of a brief dietary assessment and intervention tool for health professionals. Am J Prev Med 2011;40:67–71.CrossRef Paxton AE, Strycker LA, Toobert DJ et al. Starting the conversation performance of a brief dietary assessment and intervention tool for health professionals. Am J Prev Med 2011;40:67–71.CrossRef
16.
Zurück zum Zitat Younossi ZM, Stepanova M, Henry L et al. A disease-specific quality of life instrument for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: CLDQ-NAFLD. Liver Int 2017;37:1209–1218.CrossRef Younossi ZM, Stepanova M, Henry L et al. A disease-specific quality of life instrument for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: CLDQ-NAFLD. Liver Int 2017;37:1209–1218.CrossRef
17.
Zurück zum Zitat De Cocker KA, De Bourdeaudhuij IM, Cardon GM. What do pedometer counts represent? A comparison between pedometer data and data from four different questionnaires. Public Health Nutr 2009;12:74–81.CrossRef De Cocker KA, De Bourdeaudhuij IM, Cardon GM. What do pedometer counts represent? A comparison between pedometer data and data from four different questionnaires. Public Health Nutr 2009;12:74–81.CrossRef
18.
Zurück zum Zitat Centis E, Moscatiello S, Bugianesi E et al. Stage of change and motivation to healthier lifestyle in nonalcoholic fatty liver disease. J Hepatol 2013;58:771–777.CrossRef Centis E, Moscatiello S, Bugianesi E et al. Stage of change and motivation to healthier lifestyle in nonalcoholic fatty liver disease. J Hepatol 2013;58:771–777.CrossRef
20.
Zurück zum Zitat Konerman MA, Jones JC, Harrison SA. Pharmacotherapy for NASH: current and emerging. J Hepatol 2018;68:362–375.CrossRef Konerman MA, Jones JC, Harrison SA. Pharmacotherapy for NASH: current and emerging. J Hepatol 2018;68:362–375.CrossRef
21.
Zurück zum Zitat Yang XH, Yu HJ, Liu MW et al. The impact of a health education intervention on health behaviors and mental health among Chinese college students. J Am Coll Health 2020;68:587–592.CrossRef Yang XH, Yu HJ, Liu MW et al. The impact of a health education intervention on health behaviors and mental health among Chinese college students. J Am Coll Health 2020;68:587–592.CrossRef
22.
Zurück zum Zitat Devaux M, Sassi F, Church J et al. Exploring the relationship between education and obesity. OECD J Econ Stud 2011;1:1–40.CrossRef Devaux M, Sassi F, Church J et al. Exploring the relationship between education and obesity. OECD J Econ Stud 2011;1:1–40.CrossRef
23.
Zurück zum Zitat David K, Kowdley KV, Unalp A et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009;49:1904–1912.CrossRef David K, Kowdley KV, Unalp A et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009;49:1904–1912.CrossRef
24.
Zurück zum Zitat Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology 2016;63:1184–1189.CrossRef Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology 2016;63:1184–1189.CrossRef
Metadaten
Titel
Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention
verfasst von
Lisa Glass
Haila Asefa
Michael Volk
Anna S. Lok
Monica A. Tincopa
Publikationsdatum
27.05.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07052-9

Weitere Artikel der Ausgabe 6/2022

Digestive Diseases and Sciences 6/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.